WebRisks of breast cancer are unclear. The risk may be higher than that in cisgender men, but does appear significantly lower than the rates seen in cisgender women. Risk factors include family and genetic history of breast cancer, length of time on estrogen therapy, age when starting estrogen therapy, and possible exposure to progesterone. WebBased on hormonal and pharmacological activity, spironolactone may be considered for further research on alopecia and hirsutism in breast cancer patients. Most patients did not show increased estrogen levels with spironolactone and there were no data suggesting increased risk of breast cancer.
Association of Spironolactone Use With Risk of Cancer: A …
WebUse is limited to female patients. A typical dose of spironolactone is 100 mg per day, though doses utilized range … Alopecia related to systemic cancer therapy … The data with spironolactone are limited, but this is a relatively nontoxic therapy that can be considered for treatment of persistent alopecia following cancer therapy. WebMar 23, 2024 · Studies in rats have shown that spironolactone is associated with an increased risk of tumor growth, especially on endocrine organs (such as the thyroid) and the liver. However, human studies have continually reported results that spironolactone does not increase cancer risk in humans. "With respect to breast, uterus, ovarian and cervical ... flocked thore christmas tree
Spironolactone and Breast Cancer Risk - Dibesity Oncology
WebFeb 19, 2024 · In a previous study, there were indications that spironolactone was associated with an increased risk of ovarian cancer, a hormone-sensitive cancer, … WebAug 13, 2012 · Spironolactone is not associated with an increased risk for breast cancer in older women, according to a recent study. Breast cancer is a leading cause of death in women the world over. Treatment ... WebDec 1, 2013 · Spironolactone, an aldosterone-antagonist, is associated with gynecomastia. Digoxin, which can also cause gynecomastia, has been associated with increased incidence of breast and uterus cancers. We therefore postulated that spironolactone use might also increase these cancer risks. flocked tip swab